Furthermore, it was recently discovered that the atypical chemokine receptor ACKR3 is also upregulated in many cancers, including breast [10,11,12]; however, reports are contradictory on whether ACKR3 expression is pro- or anti-metastatic. The gene discussed is ACKR3; the disease is cancer.